Cargando…
Dexmedetomidine Protects Against Kidney Fibrosis in Diabetic Mice by Targeting miR-101-3p-Mediated EndMT
Objective: Our main purpose is to explore the effect and mechanism of Dexmedetomidine (DEX) in diabetic nephropathy fibrosis. Methods: Diabetic model was established by intraperitoneal injection of streptozotocin (STZ) treated CD-1 mice and high glucose cultured human dermal microvascular endotheli...
Autores principales: | Song, Li, Feng, Songlin, Yu, Hao, Shi, Sen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973067/ https://www.ncbi.nlm.nih.gov/pubmed/35370507 http://dx.doi.org/10.1177/15593258221083486 |
Ejemplares similares
-
Knockdown of LncRNA-H19 Ameliorates Kidney Fibrosis in Diabetic Mice by Suppressing miR-29a-Mediated EndMT
por: Shi, Sen, et al.
Publicado: (2020) -
Inhibition of miR‐21 alleviated cardiac perivascular fibrosis via repressing EndMT in T1DM
por: Li, Qianqian, et al.
Publicado: (2019) -
MicroRNAs in Kidney Fibrosis and Diabetic Nephropathy: Roles on EMT and EndMT
por: Srivastava, Swayam Prakash, et al.
Publicado: (2013) -
Modulation of EndMT by Hydrogen Sulfide in the Prevention of Cardiovascular Fibrosis
por: Testai, Lara, et al.
Publicado: (2021) -
To be EndMT or not to be, that is the question in pulmonary hypertension
por: Xiong, Jianhua
Publicado: (2015)